Content about Cardiology

February 1, 2011

Pharmacy and health policy advocates endlessly tout the cost-saving 
benefits of improved medication adherence. In January, CVS Caremark put more teeth into that argument with some dramatic new findings that should get the attention of every health plan payer.


February 1, 2011

PharmaSmart International on Monday announced new advances in its blood-pressure diagnostic and health IT kiosks, including Internet connectivity, patient data tracking and patient health record integration.

ROCHESTER, N.Y. — PharmaSmart International on Monday announced new advances in its blood-pressure diagnostic and health IT kiosks, including Internet connectivity, patient data tracking and patient health record integration.

“PharmaSmart now combines a clinically validated diagnostic tool with an easy-to-use health IT platform to offer pharmacists meaningful tools for better patient care,” stated Ashton Maaraba, PharmaSmart GM and SVP. “This represents a new era of clinical pharmacy services.”

January 14, 2011

Walgreens has announced that it is offering free blood pressure testing through Jan. 16 at all Walgreens pharmacies and Take Care Clinics nationwide, as announced Thursday on "The Oprah Winfrey Show."

DEERFIELD, Ill. — Walgreens has announced that it is offering free blood pressure testing through Jan. 16 at all Walgreens pharmacies and Take Care Clinics nationwide, as announced Thursday on "The Oprah Winfrey Show."

January 6, 2011

Patients with one or more out of four chronic diseases studied who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to findings of a new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.

WOONSOCKET, R.I. — Patients with one or more out of four chronic diseases studied who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to findings of a new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.

January 5, 2011

A designer and manufacturer of digital personal healthcare products has launched a blood-pressure monitoring system for the Apple iPhone, iPod Touch and iPad.

LAS VEGAS — A designer and manufacturer of digital personal healthcare products has launched a blood-pressure monitoring system for the Apple iPhone, iPod Touch and iPad.

IHealth Lab's iHealth blood-pressure monitoring system lets users measure and track their blood pressure and heart rate.

December 23, 2010

The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company.

EAST HANOVER, N.J. — The Food and Drug Administration on Wednesday approved Novartis Pharmaceuticals’ Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure, according to the pharma company. 

Amturnide combines the only approved direct rennin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).

November 22, 2010

Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health ...

BANNOCKBURN, Ill. Blood pressure monitor manufacturer Omron Healthcare is working with the American Heart Association to promote heart health, Omron announced.

Under the partnership, Omron is supporting the AHA’s campaign to educate healthcare providers on treatments for high blood pressure, also known as hypertension, with the goal of reaching 50,000 providers by 2013.

November 21, 2010

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

DENVER A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes and cardiac death in patients with chronic kidney disease, according to results of a new study.

 

Merck said results of a 9,000-patient clinical study showed that Vytorin (ezetimibe and simvastatin) reduced the risks by 16.1% compared with placebo. Results of the study were presented Saturday at the annual meeting of the American Society of Nephrology.

 

 

November 16, 2010

Patients taking an investigational treatment for cardiovascular disease showed big improvements in cholesterol levels, according...

WHITEHOUSE STATION, N.J. Patients taking an investigational treatment for cardiovascular disease showed big improvements in cholesterol levels, according to late-stage clinical trial results released Wednesday.

 

October 20, 2010

Combining two antiviral drugs for HIV may raise the risks of life-threatening heart problems, the...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

BURLINGTON, Mass. The market for hypertension drugs will drop by $3 billion by the end of the decade due to generic competition, according to a new report by healthcare market research firm Decision Resources.

The report, announced Tuesday, found that the market for drugs to treat high blood pressure would decline from 2009’s $26 billion to $23 billion by 2019 in the United States, United Kingdom, France, Italy, Spain and Japan.

 

September 26, 2010

Omron Healthcare earlier this month joined forces with “The Dr. Oz Show” in an integrated...

BANNOCKBURN, Ill. —Omron Healthcare earlier this month joined forces with “The Dr. Oz Show” in an integrated media partnership to help spread the word about the importance of home blood pressure monitoring.

September 6, 2010

With September marked as National Cholesterol Education Month, drug maker AstraZeneca is using the occasion...

WILMINGTON, Del. With September marked as National Cholesterol Education Month, drug maker AstraZeneca is using the occasion to push lifestyles that promote low cholesterol, the Anglo-Swedish company said.

 

AstraZeneca, which markets the cholesterol-lowering drug Crestor (rosuvastatin calcium), is pushing such habits as a healthy diet and exercise as ways to keep cholesterol down. According to the American Heart Association, 102 million Americans ages 20 years and older have borderline-high or high cholesterol.

 

 

September 1, 2010

Omron Healthcare has joined forces with "The Dr. Oz Show" in an integrated media partnership...

BANNOCKBURN, Ill. Omron Healthcare has joined forces with "The Dr. Oz Show" in an integrated media partnership to help spread the word about the importance of home blood pressure monitoring, Omron announced Thursday.

 

August 26, 2010

The Food and Drug Administration has approved a single-pill combination of two drugs made by...

EAST HANOVER, N.J. The Food and Drug Administration has approved a single-pill combination of two drugs made by Novartis for treating high blood pressure, the Swiss drug maker said Friday.

 

The FDA approved Tekamlo (aliskiren and amlodipine besylate) tablets, which combine Tekturna (aliskiren) with amlodipine, a channel blocker available as a generic. The drug is approved for treating patients who are likely to need multiple drugs to lower their blood pressure or as a replacement for patients who can’t control it using one of the drugs alone.

August 23, 2010

Drug advertisements that tie disease risks with family history can influence consumers' choice of medications...

PHILADELPHIA Drug advertisements that tie disease risks with family history can influence consumers' choice of medications and have a beneficial effect on those consumers' lifestyle choices, according to a study published in the August issue of the Journal of Applied Communication Research.

 

August 18, 2010

UnitedHealthcare and Affiliated Associations of America on Thursday announced that complimentary at-home health screening kits...

MERCER ISLAND, Wash. UnitedHealthcare and Affiliated Associations of America on Thursday announced that complimentary at-home health screening kits now are available to the approximate 9,000 AAOA employees and their families.

The kits, developed by Santa Barbara, Calif.-based BioIQ, enable individuals to more easily test for such conditions as diabetes and heart disease, and help patients work with their doctors to more quickly develop appropriate treatment plans.

 

August 5, 2010

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...

June 28, 2010

An investigational treatment made by Daiichi Sankyo for hypertension significantly lowers blood pressure in patients...

June 20, 2010

A new cholesterol drug made by Eli Lilly and Kowa Pharmaceuticals America has become available,...

June 10, 2010

The Food and Drug Administration said Friday it was evaluating data from two clinical trials...

May 24, 2010

A new study published in Circulation, the American Heart Association journal, found that cutting sugar-sweetened...

May 24, 2010

The use of at-home blood pressure monitors and Web-based reporting tools that connect clinicians and...

DENVER The use of at-home blood pressure monitors and Web-based reporting tools that connect clinicians and patients via the Internet appears to significantly improve patients’ ability to manage their high blood pressure to healthy levels, according to research from Kaiser Permanente released Friday.

May 13, 2010

An investigational drug for treating a common form of abnormal heart rhythm works better than...

May 10, 2010

A pooled analysis of 25 trials found that nut consumption may improve blood cholesterol levels....